Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01444989 · ClinicalTrials.gov registry record · NA
Development and Validation of a Quality of Life Instrument for Actinic Keratosis
A NA study, sponsored by Wake Forest University.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT01444989 is a NA study that has completed, run by Wake Forest University. The registered enrollment target is 150 participants.
The verdict
NCT01444989, a NA study, has completed, sponsored by Wake Forest University.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
Actinic keratoses (AKs) are some of the most common lesions seen by dermatologists. Flesh colored to erythematous, these lesions often present with scaling or crusting in sun damaged regions of the body. While they are physically visible and often palpable, these changes can also result in psychosocial changes in patients, including embarrassment about their skin or reduction in leisure activities to avoid further sun exposure. At the same time, AKs are known to progress in a significant number of cases to squamous cell carcinoma (SCC), a concern in terms of its metastatic potential. The primary purpose of developing this questionnaire is to examine how well it can potentially identify patients with actinic keratoses. However, since AK is associated with significant detriment to quality of life for validity/reliability assessment, the investigators propose to give a compilation of four self-assessment questionnaires (not specific to AK but validated for skin health in general) to subjects with at least one actinic keratosis and age- and sex- matched participants without AKs, defined as the control population. These will include the SKINDEX-16, the DLQI and the Skin Health Calculator, as well as a questionnaire composed of items specific to predisposition to AKs to be able to better assess the discriminatory power of the questionnaire.
Interventions
- OTHER AKRQ questionnaire
- OTHER Skindex-16, DLQI, Skin Health Calculator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2011-09 |
| Est. Completion | 2012-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01444989
The ClinicalTrials.gov registry entry for NCT01444989 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University, which has 100 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AKRQ questionnaire is the first listed.
NCT01444989 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01444989 about?
NCT01444989 is a clinical study titled "Development and Validation of a Quality of Life Instrument for Actinic Keratosis". Actinic keratoses (AKs) are some of the most common lesions seen by dermatologists. Flesh colored to erythematous, these lesions often present with scaling or crusting in sun damaged regions of the body. While they are physically visible and often palpable, these changes can also result in psychosoc...
What is the current status of trial NCT01444989?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2011-09. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01444989?
The interventions under investigation include: AKRQ questionnaire (OTHER), Skindex-16, DLQI, Skin Health Calculator (OTHER).
Who is sponsoring clinical trial NCT01444989?
This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.